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Introduction
Probiotics are live microorganisms which, when 
administered in sufficient quantities, exert a favourable 
effect on health status (FAO/WHO, 2002). Numerous 
bacterial species have been suggested to have probiotic 
effects, but lactic acid producing bacteria (Lactobacillus, 
Bifidobacterium, Streptococcus), which occur in the body 
naturally as constituents of the healthy gut microbiota, 
have gained the widest use in the practice. Some sup-
posed and confirmed effects through which probiotic 
microbes exert their favourable effects in the intestine 
are: supporting the mucosal barrier function of the gut, 
production of antimicrobial substances (e.g. bacterio-
cins), pH reduction, colonisation of the surface of the 
intestinal epithelium (competitive exclusion), immu-
nostimulatory effects, anti-inflammatory properties 
(Kumar et al., 2015). The proportion of fermented dairy 
products is increasing steadily on the market of pro-
biotic foods (Özer and Kirmaci, 2010). Commercially 
available dairy products often contain specific strains of 
the genera Lactobacillus and Bifido bacterium that meet 
the requirements listed above (Gueimonde et al., 2004). 
Environmentally conscious production is important 
during milk processing. The disposal of by-products 
arising in large quantities (including whey, which is 
the portion of milk that is left behind after removing 
the casein protein) raises environmental concerns 
(Chatzipaschali and Stamatis, 2012).
Earlier, whey was used only for animal nutrition, 
but it can be added to dairy products at a rate of 30–75% 
without reducing the enjoyment value of the pro-
ducts (Castro et al. 2012). The consumption of whey- 
based products is increasing all over the world (Boyn-
ton and Novakovic, 2014). This by-product, which 
makes up 85–95% of milk, contains valuable substances 
as it includes 55% of the nutrient content of milk: lac-
tose (45–50 g/l), soluble proteins (6–8 g/l), fats (4–5 g/l), 
and minerals (8–10% of the dry extract) (Farizoglu 
et al., 2004).
The objective of this series of experiments was to 
se lect effective probiotic strains for the development 
of a whey-based dairy product. In addition, we com-
pared the physiological effects of whey- and milkbased 
products as well as of probiotic and non-pro biotic pro-
ducts in rats.
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A b s t r a c t
In an in vitro experiment commercially available probiotic products were tested for the survival of bacteria under conditions of simulated 
human digestion either when used alone or mixed into yogurt. In the in vivo experiment the effects of feeding a whey- and milk-based 
yogurt prepared with the probiotic strain showing adequate survival in the in vitro experiment, was measured on body weight, feed con-
sumption and immune response of rats (IgG and IgA level after immunisation), on the composition and volatile fatty acid production of the 
intestinal microbiota and on the structure of intestinal villi. The Lactobacillus acidophilus (LA-15) strain had inadequate surviving ability in 
rats. Bifidobacterium animalis ssp. lactis (BB-12) improved the composition of the intestinal microflora, whereas whey-containing product 
had a mild immunostimulating effect and exerted a favourable influence on the morphology of intestinal villi. The consumption of yogurts 
increased the depth of crypts in the ileum, which resulted in enhanced secretion and thus softer faeces.
K e y  w o r d s: Bifidobacterium animalis, Lactobacillus acidophilus, rat intestine physiology, physiological effect of whey and yogurt
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Experimental
Materials and Methods
In vitro experiment. Cultures containing Bifidobac-
terium animalis ssp. lactis, or Lactobacillus acidophilus, 
or combination of probiotic strains (Lactobacillus del-
brueckii ssp. bulgaricus and Streptococcus thermophilus) 
were tested. A 10 ml suspension from each of the pro-
biotic strains was prepared and the initial germ count 
was adjusted to 108 colony forming units (CFU)/ml. 
The survival of the probiotic strains was tested in their 
original condition and subsequently after mixing them 
into a yogurt product.
Pasteurized raw material (milk or a 50:50% mix-
ture of milk and whey) was inoculated with the yogurt 
culture (0.3%) and the propionic strain. Maturation 
of the product was done at a temperature of 39–42°C 
and a pH of 4.6–4.8. After the end of the maturation 
process the yogurts were placed into a blast chiller for 
10–16 hours, and subsequently stored in a room of less 
than 10°C temperature until delivery.
The in vitro simulated human digestion process 
was modelled according to the method of Versantvoort 
et al. (2005). 
Study of the physiological effects of milk- and 
whey-based yogurt made with the selected probiotic 
strains in rats. Three yogurt products were studied: 
amilk-based probiotic (MP), a milk-based non-pro-
biotic product (M), and a probiotic one made from the 
1:1 mixture of raw milk and whey (WP). The milk was 
pasteurized at 85–90°C, the fat content was adjusted 
to 1.5% and then the raw material was cooled down to 
40–42°C. The yogurt cultures were added at that tem-
perature (FVV121 culture, 0.01%; L. acidophilus cul-
ture, 0.01%) during gentle mixing for 5 minutes. Warm 
maturation was conducted at 38–42°C for 4–5 hours, 
until the pH reached a value of 4.4. This was followed 
by cold maturation for 24 hours, during which the tem-
perature of the yogurt was reduced below 10°C.
The probiotic product was made from two commer-
cially available products containing B. animalis ssp. lactis 
(BB-12) and L. acidophilus (LA-15) strains, respectively.
The yogurts were stored in a refrigerator at +4°C tem- 
perature, and their germ counts were checked weekly.
A total of 40 mature male rats (Wistar Crl: WI BR, 
SPF, Budapest) were housed in individual cages (Tech-
niplast, Buguggiate, Italy) and fed a commercially avail-
able rat diet (S8106-S011, ssniff Spezialdiäten GmbH, 
Soest, Germany) ad libitum. Three groups of animals 
(M, MP, WP, n = 8/group) received yogurt in addition 
to the rat diet, while the control animals (C, n = 16) 
were fed only the rat diet throughout the experiment. 
The rats fed yogurt were offered rat food ad libitum 
during the day, then at 08:00 p.m. the feeders and drink-
ers were closed down. A 10 ml volume of yogurt was 
filled into the drinkers and offered to the rats between 
08:00 and 09:00 a.m., during which time the control rats 
were offered water.
On days 1 and 14 of the experiment the rats were 
inoculated intraperitoneally with 100 µg ovalbumin 
(OVA; Sigma-Aldrich, Hungary) per animal. Blood 
samples were taken before vaccination (on day 0), 
and subsequently on days 14 and 28. Half of the con- 
trol rats were immunized (Group CI, n = 8), while 
the other 8 control rats did not receive immunization 
(Group C, n = 8).
The rats were weighed weekly. Daily feed and yogurt 
consumption was recorded individually.
At the end of the experiment (on day 28) the rats 
were decapitated and bled after narcosis with carbon 
dioxide. Samples were taken from the small intestine 
and the caecum.
The experimental protocol was authorized by the 
Food Chain Safety and Animal Health Directorate of 
the Somogy County Agricultural Office, under permis-
sion number RH/162-2/2013.
Parameters examined. Immunoglobulin G (IgG) 
and immunoglobulin A (IgA) were determined from 
the blood plasma and the saliva, respectively, on days 0, 
14 and 28. For specific IgG detection, microtiter plates 
(Sigma-Aldrich, Hungary) were coated with 100 µl 
of OVA solution per each well. Aliquots of 100 µl of 
two dilutions (1:50 and 1:100) were transferred to the 
microtiter plate and incubated for 1 hour at room tem-
perature. Wells were washed 3 times with PBS-Tween, 
and then anti-rat IgG-HRP conjugate (Sigma-Aldrich, 
1:10,000) was added to each well, followed by incuba-
tion at room temperature for 1 hour. Total secretory IgA 
(sIgA) from the saliva was measured using a quanti-
tative Rat IgA ELISA kit (Kamiya Biomedical Co., USA) 
as described by the manufacturer.
From 1 g of small intestinal and caecal content, 
serial dilutions with 0.9% sterile saline solution were 
made immediately after sampling and used for micro-
biological determination. Media used and conditions of 
incubation are summarised in Table I. Incubation was 
done under aerobic (Memmert 108 incubator, Mem-
mert, Schwabach, Germany) or anaerobic conditions 
(Anaerob Jar, Merck, Darmstadt, Germany). Results 
were expressed in log10 CFU related to 1 g of sample.
If the probiotic strains could be detected from 
the small intestinal and caecal chyme pure cultures 
were obtained from the Lactobacillus and Bifidobac-
terium cultures by a single passage on the surface of 
the above-mentioned selective media and studied by 
molecular genetic tools. Partial sequences of the 16S 
rRNA coding gene of colonies picked up from pure 
cultures were determined by the use of universal bac-
terial primers (M13F-27F: TGTAAAACGACGGC-
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CAGTCAGTC-AGAGTTTGATYMTGGCTCAG 
and M13R-338R: CAGGAAACAGCTATGACCCAT- 
GCTGCCTCC CGTAGGAGT). The 5’ ends of the 
universal bacterial primers had M13 sequences to 
facilitate the sequencing reaction described later. 
A colony was directly used in a  PCR reaction. After 
amplification (96°C, 5 min; 35  cycles of 94°C 30 sec, 
62°C 45 sec, 68°C 45 sec followed by 72°C 2 min), the 
PCR product was checked on 4% MetaPhorTM (Lonza, 
USA) agarose gel (6 min 6 V cm–1, 8 min 9 V cm–1). 
Successful PCR reactions were treated with ExoSAP-
ITTM (USB, USA) at 37°C for 15 min and at 80°C for 
15 min to inactivate unconsumed dNTPs, primers and 
ExoSAP itself. This mixture was directly used in the 
sequencing reaction (Big Dye Direct Sequencing kit, 
Life Technologies, USA). Conditions of the sequencing 
reaction were: 37°C 15 min, 80°C 2 min, 96°C 1 min; 
25 cycles 96°C 10 sec, 50°C 5 sec, 60°C 4 min. Prim-
ers were complements of M13 sequences presented on 
the 5’  regions of the previously described M13F-27F 
and M13R-338R primers. The product of the sequenc-
ing reaction was purified by BigDye XTerminatorTM 
(Life Technologies, USA). The sequence was deter-
mined on an ABI-3500 fragment analyser. Sequences 
were identified on the basis of a public 16S riboso-
mal RNA sequence database (http://blast.ncbi.nlm.
nih.gov/Blast.cgi?PROGRAM=blastn&amp;BLAST_
SPEC=WGS&amp;BLAST_PROGRAMS=megaBlast 
&amp;PAGE_TYPE=BlastSearch).
The concentration of volatile fatty acids (VFA) was 
measured by gas chromatography (Shimadzu GC 2010, 
Japan; Nukol 30 m × 0.25 mm × 0.25 μm capillary col-
umn, Supelco, Bellefonte, PA, USA; FID detector, 1:50 
split ratio, 1 μl injected volume, helium 0.84 ml /min–1). 
Detector conditions: air 400 ml/min, hydrogen 47 ml/
min, temperature: injector 250°C, detector 250°C, col-
umn 150°C). 2-ethyl-butyrate (FLUKA Chemie GmbH, 
Buchs, Switzerland) was used as internal standard.
Samples for histological examination were taken 
from the duodenum (1 cm distal to the pylorus), the 
proximal part of the jejunum and the ileum (1 cm 
proximal to the ileocaecal valve opening). The samples 
were fixed in 10% buffered formaldehyde solution then 
embedded in paraffin and stained with haematoxy-
lin and eosin. The general condition of the intestinal 
mucosa, the epithelial layer covering the intestinal villi, 
the structure of the stratum villosum, quantitative and 
qualitative composition of the cells were evaluated. The 
cytomorphology of the gut-associated lymphoid tissue 
(GALT) in the ileum was also examined. The length of 
the intestinal villi and the depth of the intestinal glands 
(crypts) were measured by a histometric method (using 
an ocular micrometer).
The effect of treatment or treatment and age was 
determined by one-way and multi-factor analysis of 
variance, respectively (SPSS 10.0, 2002). The signifi-
cance of between-group differences was tested by the 
LSD post-hoc test.
Results and Discussion
Survival of the probiotic strains after in vitro 
simulated digestion. Probiotic bacterial strains could 
be cultured in a germ count of 106–107 magnitude, with 
the B. animalis ssp. lactis strains having the highest 
In vitro experiment
B. animalis ssp. lactis TOS-propionate agar medium1 supplemented 37°C, 72 h, anaerobic
 with lithium-mupirocin
L. acidophilus MRS agar 35°C, 72 h, anaerobic
L. delbrueckii ssp. bulgaricus MRS agar 35°C, 72 h, anaerobic
Streptococcus thermophilus M-17 agar supplemented with 10% lactose solution1 42°C, 24 h, anaerobic
In vivo experiment
Total aerobic bacteria blood agar 30°C, 72 h, aerobic
Total anaerobic bacteria blood agar 37°C, 48 h, anaerobic
E. coli Chromocult differentiation medium2 37°C, 24 h, aerobic
Bifidobacterium TOS-propionate agar medium1 37°C, 72 h, anaerobic
Bacteroides Schaedler’s agar3 supplemented with esculin2, neomycin2 37°C, 96 h, anaerobic
 and iron ammonium citrate3
Lactobacillus sp. MRS agar3 37°C, 72 h, anaerobic
Table I
Microbiological cultivation methods
1 Fluka, Budapest,  2 Merck, Darmstadt, Germany,  3 Sharlan Chemie, Barcelona, Spain
Bacteria Media Conditionsof incubation
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initial germ count. After in vitro digestion the colony-
forming unit counts of the B. animalis ssp. lactis bac-
teria decreased by 4 and 5 logs. The L. acidophilus, 
L. delbrueckii ssp. bulgaricus and S. thermophilus strains 
survived the conditions of simulated digestion in very 
low numbers (only 101 CFU/ml).
In the yogurt the initial germ count of probiotic 
strains was 108–109, during the digestion the germ 
counts decreased by 2–6 logs. 
Selection and testing of the appropriate probiotic 
strains require extreme circumspection. These bacteria 
have to survive the bactericidal effects occurring in the 
stomach and small intestine (gastric acid, pH, bile salts, 
proteolytic enzymes) in order to colonize the small or 
the large intestine. For this reason, it is not enough to 
test whether the probiotic strain can be cultured from 
a given product, since – as shown by our results – the 
germ count can decrease significantly even after an 
in vitro simulated digestion. The type and chemical 
composition of the food raw material selected for the 
production of probiotic products have a decisive influ-
ence on colonization of the gut by these bacteria. Yogurt 
has proved to be an ideal material (Ranadheera et al., 
2010). This has been demonstrated also by our experi-
ment, as the probiotic strains mixed in yogurt survived 
in vitro digestion in germ counts of 103–106, whereas 
their survival in their original condition was minimal: 
lactobacilli and bifidobacteria could be cultured only 
in germ counts as low as 10 to 1000.
Probiotic microbial strains used in combination 
may exert their beneficial effect more effectively than 
a single strain used alone (Timmerman et al., 2004). 
This effect probably occurs with bacteria capable of 
complementing the metabolism of one another, and is 
manifested also in the higher germ count of bacteria 
surviving digestion. In this experiment, in the yogurt 
product containing both the Lactobacillus delbrueckii 
ssp. bulgaricus and the Streptococcus thermophilus 
strains the bacteria survived the digestion procedure 
only in a germ count of 103–104. 
Despite the fact that some strains of the genus 
Bifidobacterium can survive in yogurt for a short 
period of time (Roy, 2005), Bifidobacterium animalis 
ssp. lactis was the bacterium that survived the simu-
lated human digestion procedure in the highest germ 
count (5.3 × 107). As we obtained favourable survival 
results (106 CFU/ml) for L. acidophilus strains as well, 
we decided on the combined use of L. acidophilus and 
B. animalis ssp. lactis strains in the rat experiment. 
Strains belonging to the genera Lactobacillus and 
Bifidobacterium are often included in commercially 
available dairy products (Masco et al., 2005).
Effects of the milk- and whey-based yogurt pre-
pared with the selected probiotic strains in rats. The 
germ count of probiotic yogurts was 4 × 108 ml–1 for B
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L. acidophilus and 1.6 × 108 for B. animalis ssp. lactis, 
and storage at +4°C did not decrease the viability of 
probiotic bacteria. The rats drank about 3 – 8 ml of 
yogurt each, which represented an average daily yogurt 
intake of 2 dl for a human of average body weight 
(60 kg). The result of testing under in vitro conditions 
does not necessarily mean the survival of the probiotic 
strain in the living organism. In our animal experiment 
from the small and large intestinal samples of rats of 
groups WP and MP the B. animalis ssp. lactis (YIT4121) 
strain administered as a probiotic could be identified, 
whereas the L. acidophilus (ATCC 700396) strain also 
used as a probiotic could not be detected by molecu-
lar genetic methods. The poor survival of lactobacilli 
was indicated by the bacterial counts cultured from the 
small and the large intestine, which did not differ sig-
nificantly according to whether probiotic (WP, MP) or 
non-probiotic (M) yogurt was fed (see later). Survival 
may be different under in vitro and in vivo conditions, 
as in the living organism the survival of bacteria is 
influenced also by factors as the interaction between the 
probiotic strains and the natural intestinal microbiota, 
the antimicrobial substances produced by microbes, the 
motility of the intestine and the local immune response 
(Holzapfel and Schillinger, 2002).
As the results suggested that probiotic lactobacilli 
were not present in the small and large intestine in 
sufficient numbers to exert such effects, the physiologi-
cal effects found in the experiment can be attributed 
to bifidobacteria.
Body weight, diet and yogurt drink consumption. 
The body weight of the experimental animals increased 
approximately by 20% during the four weeks of the 
experiment, and there was no significant difference 
between the groups (Table II). Although the rats con-
suming the probiotic product weighed about 10 g 
more, the difference was not statistically significant. 
Yogurt consumption increased by the second week 
and remained roughly on the same level subsequently. 
The whey-containing probiotic yogurt was consu- 
med by the rats in the highest quantity. Adding up the 
average daily feed and yogurt consumption of the rats, 
it can be seen that this was substantially higher than 
the feed consumption of the control rats, which means 
that the experimental rats consumed the yogurt in 
addition to the feed that they ate in the same amount 
as the control rats.
Immune response. There was no difference between 
the treatments in specific IgG level at the end of the 
experiment (Fig. 1A). It can be seen, however, that in 
rats fed the whey-containing probiotic product the IgG 
level increased faster and was significantly higher than 
in the rats fed the non-probiotic milk-based yogurt. 
Orally ingested whey had a more expressed beneficial 
effect on the local immune response as sIgA concentra-
tion of the saliva on day 14 was significantly higher in 
WP rats than in rats of all the other groups (Fig. 1B). 
Enzymatic degradation of the whey proteins results in 
the formation of numerous peptides of immunomodu-
latory effect, which have been shown to increase the 
concentration of specific IgG and intestinal anti-CT 
IgA after immunization of mice (Gauthier et al., 2006). 
In the present experiment, although the concentration 
of the tested antibodies increased, the consumption 
of neither milk nor whey had a detectable influence 
on the quantitative and qualitative composition of the 
lymphoid tissue (GALT) of the intestinal mucosa.
Microbiota and fermentation. One of the main 
beneficial digestive-physiological effects of probiot-
ics is stabilization of intestinal eubiosis. As had been 
expected, in our experiment the probiotic dairy pro-
ducts (WP and MP) significantly increased the counts 
of bifidobacteria in the large intestine, while in the small 
intestine a significant effect was exerted only by the 
milk-based yogurt (MP) (Table III). In addition to the 
also important Bacteroidetes (usually making up about 
10–50% of the flora) and Firmicutes strains (accounting 
Fig. 1A. Level of OVA-specific IgG measured in the blood plasma 
and Fig. 1B. sIgA measured in the saliva 14 days after the first
(on day 0) and second (day 14) immunisation
*WP significantly different from M 
*WP significantly different from all other groups
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for as much as 75%), Bifidobacterium strains consti-
tute about 10% of the large intestinal microflora. These 
microorganisms have numerous favourable physi-
ological effects; their exopolysaccharides facilitate the 
survival of bacteria in the gastrointestinal tract, they 
favourably influence the composition of the microbiota 
and the metabolic processes of microorganisms, and 
may have a beneficial effect on the immune response 
(Scott et al., 2014). The dairy products did not have an 
effect on the counts of lactobacilli in the small intestine, 
while they increased it in the large intestine, irrespec-
tive of the probiotic Bifidobacterium content. Milk (M) 
increased the propagation of E. coli in the large intes-
tine (P > 0.05), which was decreased by the probiotic 
(WP, MP), and thus in these animals an E. coli count 
similar to that found in the control rats not consuming 
the dairy product was demonstrated. Because of their 
easily fermentable lactose content, milk and whey serve 
as ideal substrates for lactobacilli and E. coli, while the 
other bifidobacteria and lactobacilli exert a competitive 
antagonistic effect on E. coli. 
Yogurt-fed rats had slightly softer faeces contain-
ing less dry matter, but the difference from the control 
was statistically significant only for rats of group M 
(Table II). Within the total quantity of the volatile fatty 
acids (VFA), the proportion of propionic acid was the 
lowest in group M and the highest in group MP.
Bifidobacteria produce acetic acid and lactic acid 
in a ratio of 3:2; however, the increase in their colony-
forming unit counts as compared to the control did not 
have a notable effect on the quantity and proportion 
of the volatile fatty acids produced. Only the non-pro - 
biotic milk-based yogurt resulted in a low propio-
nic acid production. The lower water content of the 
intestinal content in the yogurt-consuming animals 
(7–15% as compared to the control) is consistent with 
the results obtained by other researchers: the feeding 
of a lactobacillus-containing probiotic increased the 
water content of the faeces by 7–20% in rats (Wang 
et al., 2009). In the present experiment, this could be 
observed also in the rats fed a non-probiotic yogurt 
(group M), which is possibly attributable to the fact 
that the number of colony-forming lactobacilli was 
significantly higher in these animals as well. Increased 
water secretion may also be attributable to the increased 
depth of crypts between the intestinal villi (see later), as 
these results in an increase in the number of secretory 
cells located in the crypts, leading to enhanced electro-
lyte and water excretion (Nabuurs and Hoogendoorn, 
1993). Despite the laxative effect, the rats did not show 
signs of diarrhoea.
Histology. The intestinal mucosa of rats receiving 
different treatments showed a normal histological pic-
ture characteristic of the species and the age, with no 
Small intestine
Aerobic bacteria 7.92 ± 0.56 8.05 ± 0.09 8.04 ± 0.19 8.07 ± 0.45
Anaerobic bacteria 8.69 ± 0.33 9.05 ± 0.15 8.78 ± 0.20 8.87 ± 0.41
E. coli 4.99 ± 0.66 5.77 ± 0.66 4.82 ± 0.35 5.25 ± 0.56
Bifidobacterium sp. 3.31 ± 0.47a 4.38 ± 0.59ab 4.74 ± 0.40b 4.38 ± 0.64ab
Lactobacillus sp. 8.35 ± 0.16 8.56 ± 0.13 8.28 ± 0.18 8.31 ± 0.24
Ceacum
pH value 6.35 ± 0.20 6.4 ± 0.1 6.24 ± 0.1 6.5 ± 0.2
Dry matter % 24.1 ± 2.2b 22.4 ± 1.4ab 21.9 ± 0.9ab 21.0 ± 1.5a
Aerobic bacteria 9.07 ± 0.21 9.58 ± 0.21 9.20 ± 0.36 9.21 ± 0.42
Anaerobic bacteria 9.78 ± 0.06a 10.4 ± 0.13b 10.2 ± 0.08b 10.2 ± 0.31b
E. coli 6.66 ± 0.45 6.67 ± 0.39 6.66 ± 0.33 7.24 ± 0.52
Bifidobacterium sp. 5.61 ± 0.21a 7.40 ± 0.41b 7.21 ± 0.66a 6.38 ± 0.97ab
Bacteroides sp. 8.51 ± 0.54 8.82 ± 0.31 8.47 ± 0.54 8.76 ± 0.53
Lactobacillus sp. 8.89 ± 0.16a 9.34 ± 0.21b 9.37 ± 0.22 b 9.28 ± 0.25b
Total VFA (mmol/kg) 87.7 ± 26.1 96.9 ± 28.0 78.5 ± 17.1 98.6 ± 37.6
Acetic acid (%) 57.1 ± 1.2 61.1 ± 5.8 56.5 ± 5.4 64.1 ± 3.2
Propionic acid (%) 10.1 ± 1.2b 11.6 ± 2.8bc 13.0 ± 1.4c 6.2 ± 0.2a
Butyric acid (%) 32.6 ± 2.1 27.3 ± 3.9 30.4 ± 1.8 29.1 ± 3.5
Table III
Composition of the small intestinal and caecal microbiota (log10 CFU1/g), pH, dry matter
and VFA content of the caecal chyme (means ± SD)
n = 8/group;  1 CFU = colony forming unit;  a, b, c significant difference between groups (P < 0.05)
WP MPCI M
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difference in the quantitative and qualitative composi-
tion of the lymphoid tissue of the intestinal mucosa 
(GALT). The intestinal villi of the duodenum and jeju-
num were higher in group WP as compared to the other 
three treatments, but this did not cause a significant 
deviation in the calculated villus height/crypt depth 
(VH/CD) value (Fig. 2). The crypts in the ileum of 
control rats were significantly shallower, which resulted 
in a significantly higher VH/CD value as compared to 
the rats consuming yogurt.
Presumably owing to the bioactive peptides con-
tained by it, milk whey resulted in higher intestinal 
villi in the duodenum and jejunum. This is indicative 
of a more intensive proliferation or a slower apoptosis, 
and results in a larger absorptive surface and higher 
brush border enzyme activity (Pluske et al., 1996). In 
weaned piglets challenged with lipopolysaccharide, 
Xiao et al. (2016) studied the effect of a whey protein 
concentrate (WPC) on intestinal integrity, and found 
a greater intestinal VH and, in association with the for-
mer, a better intestinal barrier function. 
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